Trelegy Ellipta (FF/UMEC/VI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trelegy Ellipta (FF/UMEC/VI), covering 2018-07-13 to 2018-07-13. Get the full timeline:
Most recent: Clinical Trial Update: A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]